Wellgistics Health (WGRX)

Friday

11:02 AM

ThesisThe company's ongoing financial struggles and negative cash flow are raising concerns among investors, overshadowing potential growth opportunities.

Revenue Outlook

Metric	FY2024	FY2025
Revenue	$18M	$23M
Rev. Growth	—	+28.7%
EPS	$-6.50	$-71.50
EPS Growth	-117%	-1000%
P/E	—	—

What Moves the Stock

01Changes in healthcare regulations impacting supply chain logistics
02Volume of medical supplies ordered by hospitals
03Technological advancements in distribution efficiency
04Partnerships with major healthcare providers
05Product distribution - 70%
06Logistics services - 20%
07Consulting services - 10%
08Healthcare supply chain optimization

FY2025 Snapshot

Revenue: $23M
Rev. Growth: +28.7%
Gross Margin: -41.3%
Op. Margin: -348%
Net Margin: -434%
Net Income: $-101M
NI Growth: -1377%
EPS: $-71.50
1Y Return: -93.0%

WGRX Chart

My Notes

"Management has acknowledged the need for significant operational changes to return to profitability."
Moat: WGRX's competitive advantage is currently weak due to negative margins and high operational costs.
growth - Investors looking for turnaround opportunities in the healthcare distribution space may find WGRX appealing.
Higher interest rates could increase financing costs for WGRX, impacting its ability to invest in growth or manage operational costs…
Watch on earnings: Hospital supply order volumes, Healthcare spending trends, Regulatory changes in healthcare distribution.

One Sentence Summary:

Wellgistics Health: the story is balanced — changes in healthcare regulations impacting supply chain logistics.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance